The global COPD Drug Delivery Devices market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for COPD Drug Delivery Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of COPD Drug Delivery Devices, also provides the sales of main regions and countries. Highlights of the upcoming market potential for COPD Drug Delivery Devices, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the COPD Drug Delivery Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global COPD Drug Delivery Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for COPD Drug Delivery Devices sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
GlaxoSmithKline plc
Novartis AG
Teva Pharmaceutical Industries
Merck & Co., Inc.
Sunovion Pharmaceuticals, Inc.
Koninklijke Philips
Omron Corporation
Cipla Inc.
PARI GmbH
Segment by Type
MDI
DPI
Segment by Application
Hospital
Clinic
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of COPD Drug Delivery Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of COPD Drug Delivery Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, COPD Drug Delivery Devices sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 COPD Drug Delivery Devices Product Introduction
1.2 Market by Type
1.2.1 Global COPD Drug Delivery Devices Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 MDI
1.2.3 DPI
1.3 Market by Application
1.3.1 Global COPD Drug Delivery Devices Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global COPD Drug Delivery Devices Sales Estimates and Forecasts 2019-2030
2.2 Global COPD Drug Delivery Devices Revenue by Region
2.2.1 Global COPD Drug Delivery Devices Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global COPD Drug Delivery Devices Revenue by Region (2019-2024)
2.2.3 Global COPD Drug Delivery Devices Revenue by Region (2025-2030)
2.2.4 Global COPD Drug Delivery Devices Revenue Market Share by Region (2019-2030)
2.3 Global COPD Drug Delivery Devices Sales Estimates and Forecasts 2019-2030
2.4 Global COPD Drug Delivery Devices Sales by Region
2.4.1 Global COPD Drug Delivery Devices Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global COPD Drug Delivery Devices Sales by Region (2019-2024)
2.4.3 Global COPD Drug Delivery Devices Sales by Region (2025-2030)
2.4.4 Global COPD Drug Delivery Devices Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global COPD Drug Delivery Devices Sales by Manufacturers
3.1.1 Global COPD Drug Delivery Devices Sales by Manufacturers (2019-2024)
3.1.2 Global COPD Drug Delivery Devices Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of COPD Drug Delivery Devices in 2023
3.2 Global COPD Drug Delivery Devices Revenue by Manufacturers
3.2.1 Global COPD Drug Delivery Devices Revenue by Manufacturers (2019-2024)
3.2.2 Global COPD Drug Delivery Devices Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by COPD Drug Delivery Devices Revenue in 2023
3.3 Global Key Players of COPD Drug Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global COPD Drug Delivery Devices Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global COPD Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of COPD Drug Delivery Devices, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of COPD Drug Delivery Devices, Product Offered and Application
3.8 Global Key Manufacturers of COPD Drug Delivery Devices, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global COPD Drug Delivery Devices Sales by Type
4.1.1 Global COPD Drug Delivery Devices Historical Sales by Type (2019-2024)
4.1.2 Global COPD Drug Delivery Devices Forecasted Sales by Type (2025-2030)
4.1.3 Global COPD Drug Delivery Devices Sales Market Share by Type (2019-2030)
4.2 Global COPD Drug Delivery Devices Revenue by Type
4.2.1 Global COPD Drug Delivery Devices Historical Revenue by Type (2019-2024)
4.2.2 Global COPD Drug Delivery Devices Forecasted Revenue by Type (2025-2030)
4.2.3 Global COPD Drug Delivery Devices Revenue Market Share by Type (2019-2030)
4.3 Global COPD Drug Delivery Devices Price by Type
4.3.1 Global COPD Drug Delivery Devices Price by Type (2019-2024)
4.3.2 Global COPD Drug Delivery Devices Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global COPD Drug Delivery Devices Sales by Application
5.1.1 Global COPD Drug Delivery Devices Historical Sales by Application (2019-2024)
5.1.2 Global COPD Drug Delivery Devices Forecasted Sales by Application (2025-2030)
5.1.3 Global COPD Drug Delivery Devices Sales Market Share by Application (2019-2030)
5.2 Global COPD Drug Delivery Devices Revenue by Application
5.2.1 Global COPD Drug Delivery Devices Historical Revenue by Application (2019-2024)
5.2.2 Global COPD Drug Delivery Devices Forecasted Revenue by Application (2025-2030)
5.2.3 Global COPD Drug Delivery Devices Revenue Market Share by Application (2019-2030)
5.3 Global COPD Drug Delivery Devices Price by Application
5.3.1 Global COPD Drug Delivery Devices Price by Application (2019-2024)
5.3.2 Global COPD Drug Delivery Devices Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada COPD Drug Delivery Devices Market Size by Type
6.1.1 US & Canada COPD Drug Delivery Devices Sales by Type (2019-2030)
6.1.2 US & Canada COPD Drug Delivery Devices Revenue by Type (2019-2030)
6.2 US & Canada COPD Drug Delivery Devices Market Size by Application
6.2.1 US & Canada COPD Drug Delivery Devices Sales by Application (2019-2030)
6.2.2 US & Canada COPD Drug Delivery Devices Revenue by Application (2019-2030)
6.3 US & Canada COPD Drug Delivery Devices Market Size by Country
6.3.1 US & Canada COPD Drug Delivery Devices Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada COPD Drug Delivery Devices Sales by Country (2019-2030)
6.3.3 US & Canada COPD Drug Delivery Devices Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe COPD Drug Delivery Devices Market Size by Type
7.1.1 Europe COPD Drug Delivery Devices Sales by Type (2019-2030)
7.1.2 Europe COPD Drug Delivery Devices Revenue by Type (2019-2030)
7.2 Europe COPD Drug Delivery Devices Market Size by Application
7.2.1 Europe COPD Drug Delivery Devices Sales by Application (2019-2030)
7.2.2 Europe COPD Drug Delivery Devices Revenue by Application (2019-2030)
7.3 Europe COPD Drug Delivery Devices Market Size by Country
7.3.1 Europe COPD Drug Delivery Devices Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe COPD Drug Delivery Devices Sales by Country (2019-2030)
7.3.3 Europe COPD Drug Delivery Devices Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China COPD Drug Delivery Devices Market Size
8.1.1 China COPD Drug Delivery Devices Sales (2019-2030)
8.1.2 China COPD Drug Delivery Devices Revenue (2019-2030)
8.2 China COPD Drug Delivery Devices Market Size by Application
8.2.1 China COPD Drug Delivery Devices Sales by Application (2019-2030)
8.2.2 China COPD Drug Delivery Devices Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia COPD Drug Delivery Devices Market Size by Type
9.1.1 Asia COPD Drug Delivery Devices Sales by Type (2019-2030)
9.1.2 Asia COPD Drug Delivery Devices Revenue by Type (2019-2030)
9.2 Asia COPD Drug Delivery Devices Market Size by Application
9.2.1 Asia COPD Drug Delivery Devices Sales by Application (2019-2030)
9.2.2 Asia COPD Drug Delivery Devices Revenue by Application (2019-2030)
9.3 Asia COPD Drug Delivery Devices Sales by Region
9.3.1 Asia COPD Drug Delivery Devices Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia COPD Drug Delivery Devices Revenue by Region (2019-2030)
9.3.3 Asia COPD Drug Delivery Devices Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America COPD Drug Delivery Devices Market Size by Type
10.1.1 Middle East, Africa and Latin America COPD Drug Delivery Devices Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America COPD Drug Delivery Devices Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America COPD Drug Delivery Devices Market Size by Application
10.2.1 Middle East, Africa and Latin America COPD Drug Delivery Devices Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America COPD Drug Delivery Devices Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America COPD Drug Delivery Devices Sales by Country
10.3.1 Middle East, Africa and Latin America COPD Drug Delivery Devices Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America COPD Drug Delivery Devices Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America COPD Drug Delivery Devices Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca COPD Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 AstraZeneca COPD Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 Boehringer Ingelheim GmbH
11.2.1 Boehringer Ingelheim GmbH Company Information
11.2.2 Boehringer Ingelheim GmbH Overview
11.2.3 Boehringer Ingelheim GmbH COPD Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Boehringer Ingelheim GmbH COPD Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boehringer Ingelheim GmbH Recent Developments
11.3 GlaxoSmithKline plc
11.3.1 GlaxoSmithKline plc Company Information
11.3.2 GlaxoSmithKline plc Overview
11.3.3 GlaxoSmithKline plc COPD Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 GlaxoSmithKline plc COPD Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline plc Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Information
11.4.2 Novartis AG Overview
11.4.3 Novartis AG COPD Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Novartis AG COPD Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis AG Recent Developments
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Company Information
11.5.2 Teva Pharmaceutical Industries Overview
11.5.3 Teva Pharmaceutical Industries COPD Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Teva Pharmaceutical Industries COPD Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Teva Pharmaceutical Industries Recent Developments
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Information
11.6.2 Merck & Co., Inc. Overview
11.6.3 Merck & Co., Inc. COPD Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Merck & Co., Inc. COPD Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck & Co., Inc. Recent Developments
11.7 Sunovion Pharmaceuticals, Inc.
11.7.1 Sunovion Pharmaceuticals, Inc. Company Information
11.7.2 Sunovion Pharmaceuticals, Inc. Overview
11.7.3 Sunovion Pharmaceuticals, Inc. COPD Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Sunovion Pharmaceuticals, Inc. COPD Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sunovion Pharmaceuticals, Inc. Recent Developments
11.8 Koninklijke Philips
11.8.1 Koninklijke Philips Company Information
11.8.2 Koninklijke Philips Overview
11.8.3 Koninklijke Philips COPD Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Koninklijke Philips COPD Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Koninklijke Philips Recent Developments
11.9 Omron Corporation
11.9.1 Omron Corporation Company Information
11.9.2 Omron Corporation Overview
11.9.3 Omron Corporation COPD Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Omron Corporation COPD Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Omron Corporation Recent Developments
11.10 Cipla Inc.
11.10.1 Cipla Inc. Company Information
11.10.2 Cipla Inc. Overview
11.10.3 Cipla Inc. COPD Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Cipla Inc. COPD Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Cipla Inc. Recent Developments
11.11 PARI GmbH
11.11.1 PARI GmbH Company Information
11.11.2 PARI GmbH Overview
11.11.3 PARI GmbH COPD Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 PARI GmbH COPD Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 PARI GmbH Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 COPD Drug Delivery Devices Industry Chain Analysis
12.2 COPD Drug Delivery Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 COPD Drug Delivery Devices Production Mode & Process
12.4 COPD Drug Delivery Devices Sales and Marketing
12.4.1 COPD Drug Delivery Devices Sales Channels
12.4.2 COPD Drug Delivery Devices Distributors
12.5 COPD Drug Delivery Devices Customers
13 Market Dynamics
13.1 COPD Drug Delivery Devices Industry Trends
13.2 COPD Drug Delivery Devices Market Drivers
13.3 COPD Drug Delivery Devices Market Challenges
13.4 COPD Drug Delivery Devices Market Restraints
14 Key Findings in The Global COPD Drug Delivery Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
AstraZeneca
Boehringer Ingelheim GmbH
GlaxoSmithKline plc
Novartis AG
Teva Pharmaceutical Industries
Merck & Co., Inc.
Sunovion Pharmaceuticals, Inc.
Koninklijke Philips
Omron Corporation
Cipla Inc.
PARI GmbH
听
听
*If Applicable.
